Annual report pursuant to Section 13 and 15(d)

Private Placement (Details Textual)

v3.3.1.900
Private Placement (Details Textual) - USD ($)
1 Months Ended 12 Months Ended
Apr. 02, 2014
Apr. 02, 2014
Apr. 30, 2014
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Aug. 16, 2014
Jun. 24, 2014
May. 16, 2013
Private Placement [Line Items]                  
Securities Purchase Agreement Initiation Date       May 16, 2013          
Debt Instrument, Maturity Date       Aug. 16, 2014          
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount       4,994,425 3,261,360 3,525,904      
Amortization of Debt Discount (Premium)       $ 0 $ 964,851 $ 705,289      
Debt Conversion, Converted Instrument, Amount       0 $ 26,790,177 0      
Debt Conversion, Converted Instrument, Shares Issued   1,833,336     1,833,336        
Debt Instrument, Convertible, Beneficial Conversion Feature       0 $ 21,217,177 197,000      
Gains (Losses) on Extinguishment of Debt $ 2,084,368     0 2,084,368 0      
Stock Issued During Period, Value, Conversion of Convertible Securities $ 26,790,177       26,790,177        
Adjustments to Additional Paid in Capital, Other       $ 0 5,752,000 $ 0      
Common Stock [Member]                  
Private Placement [Line Items]                  
Stock Issued During Period, Shares, Conversion of Convertible Securities       46,023          
Stock Issued During Period, Value, Conversion of Convertible Securities         19        
Adjustments to Additional Paid in Capital, Other         $ 0        
Financing Warrant [Member]                  
Private Placement [Line Items]                  
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount       152,778 152,778 220,905      
Payments for Fees           $ 538,393      
Sale Of Warrants In Cash       $ 1,000          
Warrants Aggregate Exercise Price       $ 550,000          
Percentage Exercise Price Of Warrants Determined Based On Conversion Price Of Convertible Notes       120.00%          
Investment Warrants, Exercise Price       $ 3.60          
Percentage Of Warrants Exercise Based On Convertible Notes Conversion Price       120.00%          
Fair Value Assumptions, Exercise Price       $ 3.60   $ 2.49   $ 3.60  
Consulting Warrant [Member]                  
Private Placement [Line Items]                  
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount       146,252 278,228 278,228      
Sale Of Warrants In Cash           $ 1,500      
Investment Warrants, Exercise Price       $ 0.04          
Fair Value Assumptions, Exercise Price           $ 0.04   $ 0.04  
Financing And Consulting Warrant [Member]                  
Private Placement [Line Items]                  
Increase (Decrease) in Derivative Liabilities         $ 5,048,000 $ 20,000      
InterestPayable [Member]                  
Private Placement [Line Items]                  
Debt Conversion, Converted Instrument, Amount     $ 290,219            
Debt Conversion, Converted Instrument, Shares Issued     96,792            
Maximum [Member] | Common Stock [Member]                  
Private Placement [Line Items]                  
Stock Issued During Period, Shares, Conversion of Convertible Securities 1,930,128                
Convertible Notes Payable [Member]                  
Private Placement [Line Items]                  
Debt Instrument, Face Amount                 $ 5,500,009
Debt Instrument, Interest Rate, Stated Percentage             6.00%    
Debt Instrument, Convertible, Conversion Price $ 3.00 $ 3.00   $ 3.00          
Debt Conversion, Converted Instrument, Amount     $ 5,500,009            
Debt Conversion, Converted Instrument, Shares Issued   1,833,336